VC  Pivotal bioVenture Partners

https://pivotallifesciences.com/




     Office Locations:

501 2nd Street, Suite 200
San Francisco, CA 94107
Phone: 415-697-1002

Get all office locations for this firm with a National Database subscription or Silicon Valley Database subscription.
 

Stages:

  • Early
  • Growth
  • Late
  • Seed
 

Industries:

  • Life Sciences & Healthcare


    		•
     

    Description:

    Pivotal bioVenture Partners is a $300 million life sciences venture capital fund established in 2017. The firm invests in privately held North American and European companies focused on innovative therapeutic products and platforms to address major unmet medical needs. Pivotal bioVenture invests at all stages in a company's evolution, from company creation through mid and late stage clinical development. The seasoned investment team brings over 60 years combined biotech venture capital and company building experience from top tier funds including Novo Ventures, TPG Biotech, Bay City Capital, NEA, and SV Life Sciences. The firm announced (December 2023) the final close of Pivotal bioVenture Partners Fund II, with $389 million in capital commitments. Fund II will continue Pivotal bioVenture Partners' core strategy of investing in companies based in North America and Europe developing innovative and impactful therapeutics.


     

    Funds:


      Fund Name
      Amount
      Date
    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or Silicon Valley Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)    		No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)    		$2M-$7M
    Expansion Stage
    (also called Late-stage)    		$7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Ash Khanna PhD, MBA Venture Partner
    Glenn Batchelder Venture Partner
    Heather Preston MD Managing Partner
    Peter Bisgaard Managing Partner
    Rob Hopfner PhD, MBA, RPh Managing Partner

     

    Recent Funding Events (trailing 12 months):


      Date
      Name
      State
      Amount
      Stage

      11/05/2024
      Evommune
      CA
      $115,000,000
      Series C

      02/13/2024
      BioAge Labs
      CA
      $170,000,000
      Series D

      12/28/2023
      Heranova Lifesciences
      MA
      $13,500,000
      Seed and Seed+

     

    Portfolio companies include:

     

    Recent News: